Aerovate Therapeutics, Inc.
AVTE
$2.53
$0.0150.60%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.87M | 7.08M | 4.92M | 4.54M | 4.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.40M | 17.41M | 26.17M | 24.62M | 22.07M |
| Operating Income | -6.40M | -17.41M | -26.17M | -24.62M | -22.07M |
| Income Before Tax | -5.38M | -16.24M | -24.78M | -23.19M | -20.36M |
| Income Tax Expenses | 55.00K | -- | -- | -- | 56.00K |
| Earnings from Continuing Operations | -5.43M | -16.24M | -24.78M | -23.19M | -20.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.43M | -16.24M | -24.78M | -23.19M | -20.41M |
| EBIT | -6.40M | -17.41M | -26.17M | -24.62M | -22.07M |
| EBITDA | -6.40M | -17.19M | -26.14M | -24.59M | -22.04M |
| EPS Basic | -0.19 | -0.56 | -0.86 | -0.83 | -0.74 |
| Normalized Basic EPS | -0.12 | -0.35 | -0.54 | -0.52 | -0.46 |
| EPS Diluted | -0.19 | -0.56 | -0.86 | -0.83 | -0.74 |
| Normalized Diluted EPS | -0.12 | -0.35 | -0.54 | -0.52 | -0.46 |
| Average Basic Shares Outstanding | 28.61M | 28.86M | 28.76M | 27.80M | 27.70M |
| Average Diluted Shares Outstanding | 28.61M | 28.86M | 28.76M | 27.80M | 27.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
